Figure 1. Survival of patients with EGFR amplification in breast cancer.
A) Combination of TCGA, METABRIC, MSKCC datasets to analyze overall survival (OS) of patients comparing EGFR amplification (red line) to patients without EGFR amplification (blue line). B) OS of patients from Caris dataset with EGFR amplification (red line) compared to patients without EGFR amplification (blue line).
